Rapport Therapeutics, Inc.
RAPP
33 insider filings · Latest: Aug 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Aug 12 8:35 PM | Abraham CeesayDirector, Chief Executive Officer | Sale | 28,958 | $48.01 | $1.4M | 486,108(D) | View → |
| Aug 10, 2026 | Aug 12 8:35 PM | Abraham CeesayDirector, Chief Executive Officer | Sale | 22,541 | $46.26 | $1.0M | 515,066(D) | View → |
| Jul 27, 2026 | Jul 29 8:05 PM | Abraham CeesayDirector, Chief Executive Officer | Sale | 2,210 | $42.11 | $93.1K | 537,607(D) | View → |
| Jul 14, 2026 | Jul 15 8:15 PM | Abraham CeesayDirector, Chief Executive Officer | Sale | 8,210 | $40.00 | $328.4K | 539,817(D) | View → |
| Jun 30, 2026 | Jul 1 8:10 PM | Cheryl GaultChief Operating Officer | Sale | 10,000 | $41.58 | $415.8K | 149,914(D) | View → |
| Jun 29, 2026 | Jul 1 8:05 PM | Abraham CeesayDirector, Chief Executive Officer | Sale | 8,220 | $39.83 | $327.4K | 548,027(D) | View → |
| Jun 30, 2026 | Jun 30 8:33 PM | CHERYL GAULT | Proposed Sale | 10,000 | $40.39 | $403.9K | — | View → |
| Jun 29, 2026 | Jun 29 8:45 PM | Abraham N. Ceesay | Proposed Sale | 99,480 | $40.39 | $4.0M | — | View → |
| May 26, 2026 | May 28 8:15 PM | Third Rock Ventures V, L.P.10% Owner | Sale | 18,572 | $40.05 | $743.8K | 6,280,525(D) | View → |
| May 26, 2026 | May 27 1:16 PM | Third Rock Ventures V, L.P. | Proposed Sale | 18,572 | $40.00 | $742.9K | — | View → |
| May 11, 2026 | May 13 11:06 PM | Third Rock Ventures V, L.P.10% Owner | Sale | 133,618 | $40.24 | $5.4M | 6,299,097(D) | View → |
| May 8, 2026 | May 11 9:07 PM | Third Rock Ventures V, L.P.10% Owner | Sale | 5,018 | $40.31 | $202.3K | 6,432,715(D) | View → |
| May 7, 2026 | May 11 9:07 PM | Third Rock Ventures V, L.P.10% Owner | Sale | 271,495 | $40.12 | $10.9M | 6,437,733(D) | View → |
| May 11, 2026 | May 11 8:25 PM | Third Rock Ventures V, L.P. | Proposed Sale | 133,618 | $40.25 | $5.4M | — | View → |
| May 8, 2026 | May 8 8:57 PM | Third Rock Ventures V, L.P. | Proposed Sale | 5,018 | $40.31 | $202.3K | — | View → |
| May 7, 2026 | May 7 8:44 PM | Third Rock Ventures V, L.P. | Proposed Sale | 271,495 | $40.12 | $10.9M | — | View → |
| Apr 17, 2026 | Apr 21 11:36 PM | Third Rock Ventures V, L.P.10% Owner | Sale | 426,005 | $40.32 | $17.2M | 6,709,228(D) | View → |
| Apr 17, 2026 | Apr 21 8:55 PM | Krishnaswamy YeleswaramChief Development Officer | Sale | 20,225 | $39.99 | $808.8K | 246,426(D) | View → |
| Apr 17, 2026 | Apr 17 8:37 PM | KRISHNASWAMY YELESWARAM | Proposed Sale | 20,225 | $39.54 | $799.7K | — | View → |
| Apr 17, 2026 | Apr 17 8:25 PM | Third Rock Ventures V, L.P. | Proposed Sale | 426,005 | $40.32 | $17.2M | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Jun 10 9:57 PM | John MaraganoreDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:52 PM | Robert J PerezDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:46 PM | Steven M PaulDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:28 PM | Paul M SilvaDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:26 PM | James HealyDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:25 PM | Reid M HuberDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:24 PM | Wendy B. YoungDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:23 PM | Ramiro SanchezDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Feb 19, 2026 | Feb 20 12:05 AM | David BredtChief Scientific Officer | Option Exercise | 6,000 | $1.80 | 88,080(D) | View → |
| Feb 2, 2026 | Feb 4 9:15 PM | Jeffrey SevignyChief Medical Officer | Grant/Award | 130,000 | $27.75 | 130,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:14 PM | Abraham CeesayDirector, Chief Executive Officer | Grant/Award | 428,000 | $27.75 | 428,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:12 PM | Troy A. IgnelziChief Financial Officer | Grant/Award | 148,000 | $27.75 | 148,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:11 PM | Krishnaswamy YeleswaramChief Development Officer | Grant/Award | 120,000 | $27.75 | 120,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:09 PM | David BredtChief Scientific Officer | Grant/Award | 103,000 | $27.75 | 103,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:02 PM | Cheryl GaultChief Operating Officer | Grant/Award | 132,000 | $27.75 | 132,000(D) | View → |